Related Experiment Video
Updated: Jul 18, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Rethinking 30-day mortality risk after radical prostatectomy
Shabbir M H Alibhai1, Marc Leach, George Tomlinson
1Division of General Internal Medicine and Clinical Epidemiology, University Health Network, Toronto, Ontario, Canada. shabbir.alibhai@uhn.on.ca
Urology
|November 23, 2006
Summary
Radical prostatectomy (RP) shows similar 30-day mortality risks for men aged 60-69 and 70-79. Older men undergoing RP do not face a disproportionately higher risk compared to younger age groups.
Area of Science:
- Urology
- Oncology
- Geriatric Medicine
Background:
- Radical prostatectomy (RP) is a common treatment for prostate cancer.
- Older men undergoing RP may have a higher risk of 30-day mortality.
- The precise magnitude of this excess risk in older age groups requires characterization.
Purpose of the Study:
- To compare the 30-day mortality risk of radical prostatectomy (RP) across different age groups.
- To determine if older men (70-79 years) have a greater excess risk of mortality after RP compared to younger men (60-69 years).
Main Methods:
- Retrospective cohort study using the Ontario Cancer Registry.
- Included 11,010 men who underwent RP between 1990 and 1999.
- Compared 30-day post-RP mortality with 1-month mortality and age-matched general population mortality.
Main Results:
- Overall 30-day mortality after RP was 0.48% (53 men).
- Absolute excess 30-day mortality risk increased with age (0.18% for 50-59, 0.51% for 60-69, 0.59% for 70-79).
- Relative mortality risk was similar across age groups, approximately nine times the baseline.
Conclusions:
- Men aged 70-79 undergoing radical prostatectomy (RP) do not exhibit a greater absolute excess or relative risk of 30-day mortality compared to men aged 60-69.
- The findings suggest that age alone may not be a significant differentiating factor for short-term mortality risk after RP in these older groups.